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Abstract: This paper focuses on the design, realization, and verification of a novel phonocardiographic-
based fiber-optic sensor and adaptive signal processing system for noninvasive continuous fetal
heart rate (fHR) monitoring. Our proposed system utilizes two Mach-Zehnder interferometeric
sensors. Based on the analysis of real measurement data, we developed a simplified dynamic model
for the generation and distribution of heart sounds throughout the human body. Building on this
signal model, we then designed, implemented, and verified our adaptive signal processing system by
implementing two stochastic gradient-based algorithms: the Least Mean Square Algorithm (LMS),
and the Normalized Least Mean Square (NLMS) Algorithm. With this system we were able to extract
the fHR information from high quality fetal phonocardiograms (fPCGs), filtered from abdominal
maternal phonocardiograms (mPCGs) by performing fPCG signal peak detection. Common signal
processing methods such as linear filtering, signal subtraction, and others could not be used for this
purpose as fPCG and mPCG signals share overlapping frequency spectra. The performance of the
adaptive system was evaluated by using both qualitative (gynecological studies) and quantitative
measures such as: Signal-to-Noise Ratio—SNR, Root Mean Square Error—RMSE, Sensitivity—S+,
and Positive Predictive Value—PPV.
Keywords: interferometer; fetal heart rate (fHR); maternal heart rate (mHR); EMI-free; adaptive
system; Least Mean Squares (LMS) algorithm; Normalized Least Mean Square (NLMS) algorithm;
fetal phonocardiography (fPCG); maternal heart sounds (mHS); fetal heart sounds (fHS)
1. Introduction
The monitoring of fetal heart sound by general practitioners dates back to the second half of the
17th century when these signs were considered essential to distinguish between live and dead fetuses.
To listen to these heart sounds, the so-called Pinard’s stethoscope or its modern versions have been in
use for several decades [1–3]. With general advancements in the discipline of electrical engineering
and the arrival of Electronic Fetal Heart Monitoring or Electronic Fetal Monitoring (EFM), significant
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progress has been made in this field to date [4,5]. Currently EFM serves as a valuable diagnostic tool
to detect hypoxic conditions before and during delivery [6].
Currently, the most frequently used fetal monitoring methods by clinicians are mainly centered
on the ultrasound modality. For example, fetal echocardiography (fECHO) is used for diagnosis of
congenital heart defects (20th–23rd week of pregnancy), and cardiotocography (CTG) simultaneously
measures fetal heartbeat and maternal uterine contractions [7–10]. The current CTG technology is
well advanced and it is a routine part of modern obstetrics in all developed countries. Thanks to the
utilization of CTG, the mortality rate of newborn babies during delivery has decreased. However, one of
the disadvantages of this method is its high sensitivity to different types of noise generated by maternal
movements, which requires frequent repositioning of the ultrasound transducers. This method does
not seem suitable for long-term continuous fetal monitoring due to the potential harmful effects
of ultrasonic radiation on the fetus, which are not well understood at this stage. The truth is that
this monitoring approach is still one of the most widely used methods in clinical practice. Some of
the other main methods used for fetal heart rate monitoring are: fetal electrocardiography (fECG),
fetal phonocardiography (fPCG) and fetal magnetocardiography (fMCG). Basically, fECG shows the
electrical activity of the heart, fPCG describes its mechanical (acoustic) activity, and fMCG is a recording
of the magnetic field of the heart [11]. A comparison of the pros and cons of individual methods is
shown in Table 1.
Table 1. Summary of main methods used for the noninvasive electronic fetal heart rate monitoring.
Method Technical Specification Gestational Age (GA) Pros and Cons
CTG 2 transducers—measurementof fHR and uterine activity ≥20 weeks
− Ultrasound radiation
− No information about BTB variability
+ Smooth HR in a time line
+ Rather robust and reliable
+ Measures uterine contractions
+ Cheap
fMCG
Detection of fetal magnetic
field SQUID Sensors placed
near maternal abdomen
≥20 weeks
− Expensive
− Needs trained staff
− Easy morphological analysis due to higher
SNR
NI-fECG Standard ECG electrodes
≥20 weeks with DIP
from 28th to 37th week
+ Quite accurate
+ Safe
+ Easy to use
+ Continuous monitoring of fHR
+ future possibility of morphology of low SNR
− Susceptible to technical artifacts (e.g.,
network noises)
One of the most important parameters monitored by EFM is the fetal heart rate (fHR). The fHR
data can be acquired either invasively (by means of a scalp electrode inserted transvaginally secured
to the fetal fontanel), or non-invasively. The invasive method produces a better quality signal (higher
Signal-to-Noise Ratio—SNR), due to the fact that the heart rate is measured directly from the fetus’s
head. The invasive method provides a very important tool in improving the diagnostic quality of
conventional CTG as well as the validation of noninvasive ECG methods. Unfortunately, the invasive
approach has a number of disadvantages. Obviously, the invasive nature of this method does not
allow its utilization before delivery (before the rupture of membranes and the release of amniotic fluid).
Also during delivery, it increases the possibility of infections and endangers the pregnant woman as
well as her fetus. We can state with a fair degree of confidence that the current preferred trend in
medicine is to use noninvasive methods [12–14]. Even though noninvasive monitoring is more suitable
for ensuring the comfort and safety of both the fetus and the mother, fetal recordings are considerably
degraded by the fetus’s surrounding influences such as technical and biological artifacts, especially
by those effects generated by the mother (such as her heartbeats and uterine contractions). From a
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signal processing perspective, these undesirable signals must be reduced or removed. In this way, the
extracted fECG signals are of diagnostic quality with minimal noise contamination so that the derived
fHR information is highly accurate. The reliable separation of fECG signals from maternal recordings
thus constitutes a critical signal-processing task and offers a special challenge in our research, which
is highly focused on noninvasive continuous fetal heart rate monitoring by means of a PCG-based
fiber optic system using two interferometric measurement sensors and an adaptive system, which are
described below [15–19].
Conventional phonocardiography (PCG) is based on a noninvasive scanning of the acoustic
signals (heart sounds generated by the opening and closure of the heart valves) by means of
a microphone placed on the subject’s thorax. Therefore, the maternal PCG (mPCG) signals are acquired
by placing a microphone on the maternal chest and the fetal PCGs (fPCGs) are recorded by positioning
a microphone on the maternal abdomen. Here we describe, for the first time, an innovative method for
extraction of fPCG signals from mPCG signals using a fiber optic sensor (based on two interferometric
components) and an adaptive filtering system that implements two gradient-based algorithms (LMS
and NMLS) for continuous monitoring of fHR. As such, we present a completely new and yet unused
concept and technique in continuous fetal heart rate monitoring.
Some of the main advantages of such a system are due to the desirable characteristics of optical
fibers and fiber-optic interferometers. Fiber-optic measurement sensors are resistant to technical
artifacts such as electromagnetic interferences; therefore, they can be used in situations where it is
impossible to deploy conventional EFM methods, such as during Magnetic Resonance Imaging (MRI)
examination [20,21] or in wet environments. The literature shows that this sensor is demonstrably
more sensitive [22–26] than the currently used electret microphones [27] (acoustic sensor [28,29]).
These properties make fiber-optic sensors very convenient and suitable choices for the measurement
of desirable (fPCG) signals. As these sensors also detect the interfering mPCG signals with very
high sensitivity, it becomes essential to deploy modern digital signal processing (DSP) approaches to
accurately separate fPCG from mPCG signals.
Because the conventionally used CTG Method exposes the fetus to ultrasonic radiation, it could
be considered potentially harmful and invasive and therefore the safety of the fetus may become
compromised in long-term monitoring [30,31]. In contrast, our noninvasive fiber-optic interferometric
senor and its associated adaptive system implemented to separate fPCG from mPCG signals represent
no risk to the fetus or the mother and seem very desirable for continuous fetal heart rate monitoring
during different stages of pregnancy including labor and delivery. They eliminate all the potential
harmful impacts of the current methods used in clinical practice.
Fiber-optic technologies, or more precisely fiber-optic sensors (FOS), are gaining increased use
for biomedical purposes in a number of fast developing applications [32–56]. The utilization of
noninvasive fiber-optic interferometric sensors for vital sign (heart rate) monitoring are described
in [22,23,43,44,57–60].
The specific aim of this paper is to describe the utility of a fiber-optic interferometric sensor
and an adaptive system implementing the LMS and NLMS Algorithms for the effective extraction
of fHR information from maternal phonocardiographic recordings by performing fPCG signal peak
detection. Adaptive systems are able to change their parameters based on actual information in the
processed signal. We should also emphasis at this point that there are other powerful methods such as
the Independent Component Analysis (ICA) [61–63], Blind Source Separation (BSS) [64,65], Principal
Component Analysis (PCA) [66], Wavelet Transform Methods (WT) [67,68], and others that we could
successfully apply to fHR signal extraction. These methods and their applications to fHR signal
extraction will be the subjects of our future research reports. The core of an adaptive system is formed
by an identification (adaptive) algorithm [69–71] working in real time. We chose an adaptive algorithm
for the implementation of fHR signal extraction here as such algorithms have produced a successful
track record in many fields of science and engineering based on their high performance and reasonable
computational demands [72–74].
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Based on the analysis of real measurement data acquired by our sensor and adaptive signal
processing system, we developed a simplified dynamic signal model for the generation and distribution
of heart sounds throughout the human body. In developing our signal model we were guided
by the contributions made by ALMASI et al. [75,76], who have devoted great research efforts to
the development of a dynamic model for generating synthetic PCG signals. Our research efforts
complement theirs and enable us to generate synthetic physiological as well as pathological maternal
and fetal signals [77–79].
Our aim here is not to fully describe the details of the models for the generation and distribution
of cardiac electrical and acoustic signals in the pregnant woman’s body (such as fHR and mHR,
or more precisely fPCG and mPCG signals), but to evaluate the performance of our adaptive system
on synthetic data, which morphologically conform to the data acquired by means of interferometric
sensors used in our research. Our dynamic signal generation model, which is based on the works
reported in [80–85], allows us to continuously generate fetal and maternal electrocardiograms (fECGs
and mECGs) along with phonocardiograms (fPCG and mPCG).
The role and importance of such a dynamic signal model capable of generating realistic synthetic
data at this stage of our research and development cannot be taken lightly, as it is essential to carry
out quantitative evaluations of the experimental results and validate the soundness of the overall
system. Currently, there are no databases (Gold Standards) available for fHR signals acquired from
interferometric sensors, which were used in our experiments and in testing our methods for effective
fHR extraction. In addition, in the initial phases of developing any technology and its related clinical
applications, performing tests on pregnant women are not considered as a suitable option. It is
imperative that new technology developments and their applications to human subjects undergo
comprehensive approved clinical trials and meticulous legislative processes first. Such requirements
are notably strict and rightly so for pregnant women because their fetus is extremely sensitive to
external energies and stimuli (such as electromagnetic radiation, mechanical pressures, change in
temperature, etc.). Considering the above factors, it is evident that the utilization of synthetic data is
absolutely essential in the initial phases of research and development.
2. Methods
2.1. Fetal Phonocardiography
Fetal Phonocardiography was discovered by Kergardec, Marsac and Kennedy during the
17th century [86,87]. The heart’s mechanical activity is accompanied by the generation of a variety of
characteristic sounds. These sounds are associated with changes in the speed of blood flow, as well as
with the opening and closing of heart valves. Phonocardiography is a diagnostic method based on
evaluations of these acoustic signals (heart sounds) which are accompanied by mechanical vibrations
in the heart and its vessels [88–91].
Generally speaking, electrocardiograms (ECGs) and phonocardiograms (PCGs) belong to a group
of basic diagnostic and monitoring measurements used to describe the cardiac electrical and mechanical
activities, respectively (Figure 1). This classification is associated with the measurement technique
used. ECG machines and cardiac monitors sense biopotentials through bioelectrodes placed on a test
subject’s body, while PCG recordings are based on acoustic signals picked up by means of a microphone.
The PCG signal is composed of two main acoustic components – the first (S1) and the second (S2) heart
sounds. The first heart sound (systolic) is associated with the closure of the bicuspid and tricuspid
valves at the beginning of the systole, and S1 corresponds to the peak of the R wave in the ECG signal.
However, the second heart sound (S2) (diastolic) is generated by the closure of the semilunar valves,
and its beginning and length are associated with the T wave on the ECG signal.
Phonocardiograms also include other heart sounds. The third heart sound (S3) (pre-diastolic) is
associated with a valve muscle quivering during fast blood flow into the valvesm while the fourth heart
sound (S4) (pre-systolic) signals a quivering valve muscle during systole in atria. S3 and S4 are not
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common for adults, and their presence is a sign of valvular insufficiency (the so-called proto-diastolic
and presystolic gallop) [92,93].
In phonocardiography, different characteristics such as rate, frequency, and duration or changes
in individual parts of the recorded cardiac acoustic signal are measured. Thanks to PCG and ECG
signals clinicians are able to diagnose a variety of heart diseases in adults [94] and in fetuses [95] alike.
P
R
Q S
T
S1
1st cardiac sound
S2
2nd cardiac sound
ECG
PCG
S1 S1S1 S2S2
Figure 1. Sample recordings of electrocardiogram (ECG) and phonocardiography (PCG) signals.
2.2. Non-Invasive Measurement Probe and Measurement Scheme
Our noninvasive adaptive system utilizes two interferometric sensors (described in Section 2.2),
which monitor the mechanical (acoustic) activity of the heart. The sensor is comprised of Mach-Zehnder
fiber optic interferometers formed by 1 × 2 and 3 × 3 power couplers with an even split ratio.
Interferometers belong to the highest-performance group of optical sensors as they are capable of
measuring even tiny differences in the optical fiber length and the fiber core refractive index. These
differences can be measured on the scale of the wavelength of the light source. The Mach-Zehnder
interferometer is the most common configuration. The source is divided into two fiber arms
forming the reference and the measurement paths. The measurement fiber is encapsulated into
polydimethylsiloxane (PDMS) [56,96] constructing the acoustic-sensitive probe (Figure 2), while
the reference fiber stays in a stable environment. The output beams then recombine at a second
3 × 3 coupler terminated in photodetectors. The output optical intensity after 3× 3 coupler can be
described by the following equation
In = An + Bn cos [φ(t) + φdri f t(t) +
2pi
3
(n− 1)], (1)
where n is the coupler’s output index with a value of 1, 2 or 3, An is the mean value of the optical
intensity (DC component), Bn is the optical intensity variation amplitude depending on fringe visibility,
φ(t) is the signal of interest, and φdri f t(t) is the quasi-static phase shift due to coupler properties, such as
dependence on hydrostatic pressure, temperature, and polarization which can be compensated during
the phase demodulation step. As with any interferometric method, a demodulation algorithm is
required for proper signal extraction. The use of 3 × 3 couplers enables a passive demodulation using
the algorithm described in [97].
The measurements probe was encapsulated in PDMS with the designation of Sylgard 184, which
is a two-component casting compound: the A component creates its own pre-polymer and the
B component is a curing agent. Both components are mixed together with a weight ratio of 10:1 (A:B)
according to the manufacturer’s datasheets. Bubbles and microbubbles that result from the combination
of the pre-polymer and the curing agent can be removed using an ultrasonic bath. Homogeneity of the
connection is achieved by using a laboratory shaker. The measurement probe contains two connectors
of FC/APC type.
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Figure 2. Noninvasive interferometric measurement probe.
The basic scheme for the noninvasive PPG-based fiber-optic adaptive system for fHR monitoring
by means of two interferometric measurement sensors placed on the chest and abdomen is shown
in Figure 3. Sensors are placed on the maternal body by self-adhesive straps of 10 × 10 mm.
The measurement sensor weighs 150 g and has a circular shape with a 100 mm diameter.
FIR
!lter
-
+
AAPreprocessing
Preprocessing
Optical
interrogator
system and
DSP unit
Figure 3. Basic schematic diagram for our noninvasive PPG-based interferometric sensors and adaptive
system for fHR monitoring.
Based on Figure 3, we can contemplate 3 approaches on how to eliminate the undesirable mPCG
signal, which contaminates the abdominally recorded fPCG signal:
• Direct Signal Subtraction: The signal detected on the abdomen called as aPCG signal is the sum
of fPCG and mPCG signals. The easiest method for removing the undesirable mPCG from the
aPCG signal is a direct subtraction of the values mTM(n) from ( f + m)AB(n). This approach
cannot be used in practice as mPCGT measured by the thoracic fiber-optic sensor (IST) is not
identical to the mPCGA measured by the abdominal fiber-optic sensor (ISA). When the signal
spreads from the maternal heart to the abdomen, it is influenced by different factors in the
unknown body environment such as distortions due to interferences and delay caused by the
signal distribution in the human body. This fact is supported by real measurements (as explained
in Section 3).
• Linear Filtering: The next method is to use linear filtering, i.e., frequency selective filtering.
However, like direct signal subtraction, linear filtering cannot effectively eliminate the undesirable
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mPCG signal as the desired signal (fPCG) and the unwanted signal (mPCG) share overlapping
spectra (Figure 4).
• Adaptive Filtering: If we accept the unknown environment confined between the thoracic and
abdominal fiber-optic sensors as linear, we can successfully use an adaptive filter to eliminate the
fPCG signal from the aPCG signal. As an adaptive filter, the well-known FIR filter [98] whose
coefficients are continuously updated by an adaptive algorithm (such as LMS or NLMS) could be
used. This algorithm monitors the input and output signals from the filter, and from the error
signal e(n), it tries to set filter coefficients most optimally in order to minimize the difference
between the output and the required (ideal) signal. The aim of the filter is to reach a state in
which the filtered thoracic mPCGT signal is the most similar to the abdominal mPCGA signal,
which contaminates the fPCG signal reaching the abdominal part and whose value could be
subsequently subtracted (eliminated).
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Figure 4. Normalized Power Spectrum Density of data acquired from the test subject.
Figure 3 shows the maternal and fetal hearts as two complex biosignal generators, which are
mutually and acoustically separated from each other and work autonomously. From a signal processing
point of view the mHEART serves as the biosource of the unwanted signal, whereas the fHEART is the
biosource for the desired signal.
To further process, record, and transfer the above mentioned signals it is necessary to perform
a number of operations on them, which are achieved by the Optical Interrogator System and DSP
Unit. These processes (amplification, digitization, demodulation, filtering) are realized in the so-called
pre-processing block. Pre-processing is realized by means of the well-known techniques, thoroughly
described in technical literature, such as [22,99,100].
The amplification and digitization of the maternal and fetal signals are realized by means of the
NI-USB 6210 card, which has a 16-bit Analog-to-Digital Convertor (ADC) with a built-in amplifier
enabling the choice of amplification gains in steps of 1, 5, 10 and 50. The associated software support
development environment of this card, LabVIEW, enables further digital processing of the data.
In this application, the scanning and symmetric demodulation of data is implemented in the form of
immediate variance of phase information and digital filtering.
It is assumed that the mTM(n) signal processing block produces nearly ideal (noise-free) maternal
PCG signals. These are obtained by applying conventional pre-processing techniques to the IST input
signal. To compensate for the drift (due to fluctuations of zero isoline and breathing), we selected
a lower corner frequency of 0.5 Hz. An upper corner frequency is defined especially by the
phonocardiography frequency of the heart, which typically comprises frequencies ranging from
10 to 400 Hz, thus the upper marginal frequency must be set to 400 Hz [99–101].
Sensors 2017, 17, 890 8 of 26
In our experiments, two inputs signals were considered (since we used two interferometric
sensors). The first input (reference) signal that was fed into a pre-processing block is the maternal
thoracic PCG signal represented by IST in the block diagram. The maternal PCG signal reflects the
activity of the maternal heart (mHR). From the signal processing point of view, the mPCG signal is
an unwanted signal (noise) which contaminates the desired fPCG signal. The mPCG signal is digitized
by using the ADC mentioned above. In all of our experiments, we selected a sampling frequency
fsr = 1 kHz.
The second (primary) input to the experimental system shown in Figure 3 was a signal measured
in the maternal abdomen represented as ISA, which mainly reflects the activity of the fetal heart (fHR).
Here, we also used conventional pre-processing techniques to eliminate basic unwanted elements,
which contaminate the ( f +m)AB(n) outputs.
By using linear filtering we were able to eliminate only those signal components whose spectra
did not overlap with the useful fPCG signal (provided that a predictive value was maintained).
2.3. Stochastic Gradient Based Adaptation
To carry out our experiments, we used an adaptive system based on the root mean square error
(RMSE) criterion. Stochastic approaches require a large number of measurements to enable us to
perform adequate statistics. This approach leads to the Least Mean Square Algorithm or its normalized
version (LMS, NLMS), which are the basic representatives of stochastic gradient-based adaptation
methods [102–104].
2.3.1. Implementation of Adaptive LMS Algorithm
Figure 5 shows the basic scheme for an adaptive N-th order FIR filter with transversal structure
and implemented by using the LMS Algorithm. Each iteration of the LMS Algorithm requires the
implementation of 3 different steps, respectively. First of all, a value of the output of the FIR filter y(n)
is calculated according to Equation (2), valid in R:
y(n) = ~wT(n)~x(n) =
N
∑
i=0
wi(n)x(n− i). (2)
Subsequently, a value of the estimated error signal e(n) is calculated according to Equation (3)
in R, thus:
e(n) = d(n)− y(n). (3)
And finally, the values of vector scales ~w(n) of a relevant FIR filter are updated for the subsequent
iteration according to Equation (4), valid in R.
~w(n+ 1) = ~w(n) + 2µe(n)~x(n),
~w(n+ 1) = ~w(n) + kµe(n)~x(n),
~w(n+ 1)− ~w(n) = 2µ[d(n)− y(n)]~x(n),
= δ~h(n) ∀n ∈ Z+,
~h(n+ 1) =~h(n) + δ~h(n) ∀n ∈ Z+.
(4)
The implementation of the LMS Algorithm in R can be summarized as follows:
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BEGIN ~w(n = 0) =~0
FOR (n = 1, 2, ..., N) :
y(n) = ~wT(n)~x(n)
e(n) = d(n)− y(n)
~w(n+ 1) = ~w(n) + kµe(n)~x(n)
(5)
Figure 5. Basic scheme of an adaptive N-th order FIR filter with transversal structure and the
LMS Algorithm.
2.3.2. The Normalized Least Mean Square (NLMS) Algorithm
The Normalized LMS Algorithm (NLMS) is a variant of the LMS Algorithm with the added
advantage of an accelerated convergence speed and a reasonable computational cost [105]. In this
algorithm a normalized step-size µn is selected, which results in a stable and fast converging adaptation
process [106].
If we consider the step size in Equation (5) to be a variable and not a constant, i.e., the equation is
modified as follows:
~w(n+ 1) = ~w(n) + µ(n)e(n)~x(n), (6)
where the step-size can be described as:
µ(n) =
µ
δ+~xT(n)~x(n)
, (7)
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which means that this parameter is proportional to the inverse of the average of the total energy at
the filter tap inputs. That property compensates the main drawback of the standard LMS algorithm,
which is sensitive to the scaling of its input x(n):
~w(n) = ~w(n− 1) + µ e(n)~x(n)
δ+~xT(n)~x(n)
, (8)
where µ ∈ (0, 2] δ > 0. Note that δ is the regularization parameter, which also ensures the computability
of Equation (8) (prevents its denominator from becoming zero) in the case of a zero input [107].
3. Results
The first step in our work reported here was to model the synthetic signals (IST and ISA) based
upon real measurements made from the interferometric sensors placed on the test subject’s thorax
and abdomen (Figure 6). Real raw data were acquired from a group of 10 volunteer pregnant
women (GA = 35–42 weeks, in a suitable research laboratory environment after obtaining their written
informed consent to participate in this study. The test subjects were between the ages of 19 and
33 years, their weights were between 49 and 98 kg and their heights were between 152 and 198 cm.
No significant differences were found in the quality of recorded signals based on a subject’s age, weight,
and height. We captured a relevant period of signals from our designed and patented interferometric
sensors. The acquired data were used as a basis for mPCG and fPCG signal model development
and validation. The main objective in signal modelling was to obtain the primary signals mTM(n)
from the thorax and mAM(n) from the abdomen. We dedicated substantial efforts to ensure that
these synthetic signals resembled, as closely as possible, those data obtained from real measurements
sensed by the abdominal and thoracic interferometric sensors. Real measurements were also necessary
because there are currently no databases of mPCG and fPCG signals recorded from fiber-optic sensors,
or more precisely from fiber-optic interferometers encapsulated in PDMS enclosures, which were used
to satisfy the design and verification requirements of our adaptive signal processing algorithms. Based
upon experimental results in our research, we have been able to create a publicly available database of
maternal and fetal PCG signals, which could be used by researchers in this field to test their signal
processing algorithms and validate their methods.
The novel sensor designed by our research team has yet to be approved by the relevant medical
device regulatory authorities so that we would be able to carry out clinical trials on pregnant women.
These regulations are extraordinarily strict for pregnant women as an unborn fetus is extremely
sensitive to external factors (such as electromagnetic radiation, mechanical pressure, change in
temperature, and others). Considering these practical facts, the necessity to use synthetic data in the
early stages of our developmental work becomes indispensable.
The implemented fPCG and mPCG signal models used in our research are based
on signals that were produced by means of our ECG signal generator and modelling
of sound distribution in the human body. The models for fPCG and mPCG signals are
inspired by real data acquired from interferometric sensors. The models predict that heartbeat
activity causes (triggers) subsequent mechanical effects, which are distributed throughout the
human body, and then reflected and attenuated after a certain period of time [108–110].
Our results confirm those obtained by Nagel et al. [111], who modeled maternal heart sounds (mHS)
as periodic signals known as maternal pulses that originate due to blood flow sound within maternal
arteries with higher amplitudes relative to fetal heart sounds (fHS).
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Figure 6. Sample plots of real raw data acquired from the thoracic and abdominal sensors of two
different test subjects. (a) volunteer No. 1; (b) volunteer No. 2.
The advantage of this conceptualization of modelling the fetal heartbeats is that it allows us to
superimpose the fPCG signal on an abdominal signal, i.e., (m+ f )AB(n), thus producing a primary
signal suitable for experimentation with adaptive systems.
Figure 7 shows the modelled raw signal (IST) measured on the thoracic region. Here, we can
observe the breathing activity of a pregnant woman (mRR) expressed as respiration per minute
(rpm). In detailed view, we can see the mPCG signal which is superimposed on the breathing activity
expressed as beats per minute (bpm).
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Figure 7. Modelled raw signal measured by IST in the abdominal region (mRR ∈ <12–16> rpm;
mHR ∈ <65–85> bpm). (Left) 60 s; (Right) detail in the form of 2.3 s.
The implemented model capturing the maternal and fetal heartbeat activities shows that the fetal
heart activity is decreased while dispersing through the body and is not seen in the thoracic part. This
is a necessary condition for being able to use this signal for adaptive filtering. Our signal generator
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enables us to model the variability of respiration and heart rate activity as well [112–115]. In our
experiments, we used 20-min long records of which 10 min were physiological while the remaining
10 min were pathological. Our signal generator can also model fetal gestation age from the 20th to
42nd week of pregnancy. For our experiments, we created data with a fetal gestation age (GA) of
35 weeks. The GA has a primary influence on the value of the SNR. Physiological and pathological
data were modelled following the IFGO (International Federation of Gynaecology and Obstetrics)
Recommendations. As we mentioned above, our sensor is more sensitive to sensing the fPCG than the
mPCG signal. This property, as well as the difference between the data measured by the interferometers
and conventional PCG curves, was considered when we modelled the fECG and mPCG signals for
our experiments.
Figure 8 shows the modelled raw ISA signal in the abdominal region. Here, we can see the
dominating breathing activity of a pregnant woman (mRR). In the detailed view, we can see the
mPCG and fPCG signals which are superimposed on the breathing activity. The measurement clearly
shows that the determination of fHR is not linear because there is a dominant maternal part mPCG
in the signal. It is evident that the fPCG signal has to be obtained by means of advanced signal
processing methods.
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Figure 8. Modelled raw signal represented by ISA in the abdominal region (mRR ∈ <12–16> rpm;
mHR ∈ <65–85> bpm, fHR ∈ <80–155> bpm, GA = 35 weeks, orientation of fetus: Right Occiput
Posterior (ROP)). (Left) 60 s; (Right) detail in the form of 2.3 ss.
Figure 9 shows an ideal mPCG signal after the removal of the maternal breathing artifacts
(We used a second order Butterworth band-pass filter with corner frequencies fL = 0.75 Hz, fH = 400 Hz,
respectively). This signal serves as a reference input signal for the adaptive system. On the basis of the
obtained results we can determine mHR.
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Figure 9. Recording of a reference signal for the adaptive system represented by IST in the
thoracic region.
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Figure 10 shows a modelled signal measured by the abdominal sensor after the removal of
maternal breathing artifacts. This signal is formed by a mixture of fPCG and mPCG signals. It is
evident that the level of mPCG signal is higher than that of the fPCG signal. This measured signal
does not allow us to determine the fHR without any further processing. This signal is a primary input
of our implemented adaptive system.
Figure 11a shows the adaptive system output when using the LMS Algorithm and Figure 11b
shows the output when using the NLMS Algorithm. The obtained results illustrate that the mPCG
signal has been significantly suppressed. We observe that the elimination of the maternal component
is not ideal and it is still present in the estimated signal. Nevertheless, it is attenuated well below the
fPCG signal level. After this processing step, we can determine the fHR from the estimated fPCG
signal by means of conventional signal processing techniques [90,116,117].
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Figure 10. Input signal of the adaptive system formed by a mixture of maternal heart rate (mHR) and
fetal heart rate (fHR).
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Figure 11. Output of the adaptive system when using (a) the Least Mean Square Algorithm (LMS) and
(b) the Normalized Least Mean Square (NLMS) Algorithms.
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The parameters of both adaptive algorithms were set empirically based on experiments. As for
the LMS Algorithm, we set the filter order N = 38 and the convergence constant µ = 0.1598. As for the
NLMS Algorithm, an N = 61 with an initial µ = 0.1 were used. The primary and reference inputs of the
adaptive systems were identical for both algorithms due to a corrective verification of the results.
Note the peak at the beginning of the estimated signal in Figure 11. It is caused by the fact that the
algorithm is not able to converge to the optimal value (does not set the optimal step size) fast enough.
The worse results of the LMS Algorithm might be caused by a poor choice of the convergence constant.
In the case of the NLMS Algorithm, the value of the convergence constant varies and consequently
this limitation is removed.
Objective methods for the evaluation of filtering quality require a reference fPCG signal from
which we can determine the fHR. Currently, there are no references available to represent the outputs
of interferometric sensors, and thus this seems to be quite a suitable way to objectively verify the
utilization of the proposed model. Figure 12 shows the reference source of the fPCG signal that enables
the determination of the fHR.
Time (s)
0 1 2 3 4 5 6 7 8 9 10
A
m
pl
itu
de
 (-
)
-0.5
0
0.5
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1
.fS2
.fS1 .fS1
.fS2
Figure 12. Modelled reference (ideal) signal represented by ISA in the abdominal region without
a maternal component (fHR ∈ <80–155> bpm, GA = 35 weeks, fetus position: Right Occiput
Posterior (ROP)).
Figure 13a shows the reference physiological fHR time course together with its predicted tracings
determined from the fiber-optic sensor and adaptive systems using the LMS and NLMS Algorithms.
Figure 13b shows these time courses for a pathological fHR. Our experiments confirmed the hypothesis
that filtering efficacy is influenced by neither the physiological nor the pathological states of the
fHR tracings.
Figure 13 confirms that the LMS Algorithm causes a decrease in the estimated fHR values since it
eliminates some of the desired fS1 sounds in addition to the undesired maternal sounds. In contrast,
the fHR waveform estimated by the NLMS Algorithm does not significantly differ from the fHR
reference time course and therefore it is more suitable for fHR detection.
In order to compare the differences between the reference and predicted fHRs, we made use of the
Bland-Altman plots [118]. The differences between the reference and the predicted traces, re f − predic,
are plotted against the average, (re f + predic)/2. The reproducibility is considered to be good if 95 %
of the results lie within a ±1.96 SD (Standard Deviation) range.
Figure 14 shows the Bland-Altman statistics for reference and predicted values of fHR when using
(a) the LMS; and (b) the NLMS Algorithms. The fetal heart rate is expressed in beats per minute (bpm).
For the entire data set using the LMS Algorithm (608 samples), 94.74 % of the values lie within the
±1.96 SD range for the fetal heart rate determination. For the entire data set using the NLMS Algorithm
(611 samples), 95.07 % of the values lie within the ±1.96 SD range for the fetal heart rate determination.
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Figure 13. Comparison of reference and predicted time course of fHR (a) physiological case;
(b) pathological case.
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Figure 14. Bland-Altman statistics for reference and predicted values of fHR for (a) the LMS Algorithm;
(b) The NLMS Algorithm.
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Furthermore, the Bland-Altman statistics show that the error between the reference and the
predicted fetal heart rate is twice as high when using the LMS Algorithm. Possible explanations for
this are described in the text above.
Figure 15 shows a detailed comparison between the reference and filtered fPCG signals. It is
evident that the filtered signal contains missing parts that negatively influences the detection of
the necessary peaks for the determination of the fHR. This leads to a lower sensitivity and positive
predicative value in fHR determination.
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Figure 15. Detailed analysis of output from the adaptive system using (a) the LMS; and (b) the
NLMS Algorithms.
The value of SNRinp can be calculated by using the following equation:
SNRinp = 10 log10
∑N−1n=1
[
siguse f (n)
]2
∑N−1n=1
[
signois(n)− siguse f (n)
]2 , (9)
where siguse f (n) is the desired signal (modelled reference time course of IST , i.e., fPCG) and signois(n)
is the noise or unwanted signal (mPCG as measured in the abdominal region). In the software
implementation described above, because the unwanted signal (noise) is formed by the addition of an
ideal fPCG and IST after their spread in the unknown environment of the human body, it is necessary
to subtract the desired signal from the unwanted signal (noise) in the denominator of Equation (9).
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The next filtering performance metric is the output SNRout, which is defined by Equation (10).
Based on SNRinp and SNRout, we can determine how much the SNR value has improved (SNRimprov).
SNRout = 10 log10
∑N−1n=1 [sigdes(n)]
2
∑N−1n=1
[
sigpredic(n)− siguse f (n)
]2 , (10)
where sigdes(n) is again the desired signal and sigpredic(n) is a predicted (estimated) signal, or more
precisely, the output from the adaptive filtering system. In Equation (9), it is necessary to subtract the
desired signal from the predicted value in the denominator as the aim is to determine the noise signal
that corresponds to the error signal.
By using the values of SNRout and SNRinp, we can determine the efficiency of the implemented
adaptive filters (Tables 2 and 3). The prediction quality of these signal processing systems can be
verified by the so-called predicative error, which shows the degree of inaccuracy between the predicted
and the original output. In practice, we mostly use Mean Squared Error (further MSE) or more
specifically the Root Mean Squared Error (RMSE) value defined by Equation (11).
RMSE =
√
1
n
n
∑
i=1
(
sigdes − sigpredic
)2
(11)
To evaluate the peak detection success rate of our algorithms we can use two parameters. The first
parameter is sensitivity, further labelled as S+, which shows what percentage of all peaks included in
the examined signal were detected. The Sensitivity parameter S+ is defined by Equation (12).
S+[%] =
TP
TP+ FN
· 100, (12)
where TP is the number of correctly detected peaks (significant points) and FN is the number of
undetected peaks.
The second parameter used for specifying the successful detection rate of peaks is the Positive
Predictive Value—PPV. It is the probability of the real occurrence of a peak (significant point) during
its positive detection by a detector. The PPV is expressed by Equation (13).
PPV[%] =
TP
TP+ FN
· 100 (13)
In Equation (13), TP is the number of correctly detected peaks and FP is the number of falsely
detected peaks.
Tables 2 and 3 tabulate the obtained results expressed in terms of quantitative measures when
using the LMS and NLMS Algorithms, respectively. We carried out 10 independent experiments where
we changed SNRinp, which was dependent on the utilized model. In real measurements, SNRinp is
influenced by the location of the sensor, the position of a fetus in the womb, gestation age, and other
factors. Our experimental results demonstrate that the quality of signal filtering directly depends
on SNRinp.
The results (Tables 2 and 3) show that the LMS Algorithm achieves better outcomes in terms
of SNRout and RMSE metrics, while the NLMS Algorithm produces superior S+ and PPV values.
This happens due to the fact that the LMS Algorithm very often misses some peaks or fS1s (Figure 15a)
and consequently generates inferior S+ and PPV values even though it closely follows the reference
signal. For more accurate fHR determination (Figure 15b), however, it is more suitable to use the
NLMS Algorithm which, on the one hand, follows the reference signal less closely, but, on the other
hand, does not miss signal peaks (fS1s) because it automatically adjusts the convergence constant µ
(in contrast to what happens in the LMS Algorithm where no such adjustments are made).
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Table 2. Experimental result when using the LMS Algorithm.
SNRinp (dB) SNRout (dB) RMSE (mV) S+ (%) PPV (%)
−9.1497 1.8467 0.0289 95.7145 98.5401
−3.6984 2.1514 0.0317 96.4967 98.5417
−5.9841 3.4791 0.0497 97.1574 98.6053
−4.1385 0.2001 0.0304 91.5781 97.9471
−6.4717 −2.7197 0.0241 87.7339 96.5812
−4.2581 2.0964 0.0301 96.1987 98.3271
−7.5717 2.9417 0.0431 96.7417 98.5981
−8.1741 2.0114 0.0291 96.2852 98.4179
−3.1741 3.1314 0.0478 96.9517 98.3271
−10.3947 −0.3971 0.0209 89.4719 96.9547
Table 3. Experimental results when using the NLMS Algorithm.
SNRinp (dB) SNRout (dB) RMSE (mV) S+ (%) PPV (%)
−9.1497 1.5414 0.0234 97.8714 98.8475
−3.6984 1.9771 0.0287 97.0167 98.1394
−5.9841 3.2419 0.0432 98.8471 98.8417
−4.1385 0.2141 0.0217 95.6717 98.6614
−6.4717 0.0187 0.0281 95.1423 97.7491
−4.2581 1.8874 0.0279 97.5140 98.3405
−7.5717 2.5173 0.0407 98.3524 98.6477
−8.1741 1.7491 0.0259 98.1415 98.3069
−3.1741 2.6524 0.0427 97.9146 98.7421
−10.3947 0.0350 0.0185 95.0297 97.8140
4. Discussion
Fetal PCG monitoring is based on a passive acoustic technique (our fiber-optic interferometric
sensors), where no energy is transmitted to the human body [20,119–121]. It offers clinically useful
information that cannot be obtained with other methods such as ECG, MCG, Pulse Oximetry and
Ultrasound. Various studies have proposed, extracted, and reported different parameters that carry
useful diagnostic information about the fetus [122–129].
We had to use synthetic data in our research as noninvasive and nonintrusive sensors (like those
used in our system) are not currently used in clinical practice: thus it was completely unrealistic to
think about carrying out experimental tests using real maternal and fetal data to noninvasively detect
fetal hypoxic conditions during different stages of pregnancy. For verification purposes, we used
models that generate maternal and fetal signals with properties similar to real data acquired in clinical
practice. These data also provided us with realistic reference signals for the quantitative evaluation
of the realized systems, including the modelling of fetal hypoxic states without causing any risk or
danger to the mother and her fetus.
To the best of our knowledge, this is pioneering work and the first study of its kind to explore the
frontiers of noninvasive continuous fetal heart rate monitoring by means of fiber-optic interferometric
sensors. We present a number of original and yet unpublished results. The follow-up research
will be focused on the extension of our experiments and tests in clinical practice; at that time,
measurements will be carried out on pregnant women. Fiber-optic sensors are resistant to technical
artifacts such as electromagnetic interferences (EMI), and they can be used in Magnetic Resonance
Imaging (MRI) environments or under wet conditions. The functionality of our sensor and adaptive
filtering system was assessed by both qualitative (assessments made by gynecologists) and quantitative
signal processing performance measures such as: SNR, RMSE, sensitivity S+, and positive predicative
value PPV.
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The basic drawback of fiber-optic interferometry is the need for a reference channel. The basis of
interferometry is the measurement of differences between sensor and reference channels. The reference
channel of the interferometer must be designed so that it allows to eliminate most of the unwanted
signals. Thermal phenomena, mechanical changes, and other factors generate a background signal
(noise). To address this issue or more precisely the need for the reference channel (position and
encapsulation) is critical according to sensor sensitivity which must be taken into account in the design
of a fiber-optic interferometer [56,130–134].
Even though the diagnostic potential of the fPCG signal is high, its processing and analysis are
rather challenging. Fetal heart sound (fHS) signals could be relatively weak and have a low SNR
due to the following factors: the uncertainty associated with the presence of the S2 component of the
fetal heart sounds in the de-noised fPCG signal [109], the proximity of fHS signals to the threshold
of audibility, which may lead to problems of degree and accuracy [135], the spread and attenuation
of generated heart sounds through a time-varying transmission path (made up of amniotic fluid, the
uterine muscular wall, bones, cartilage and layers of fat tissue). At the boundaries of each of these
layers, heart sounds are attenuated, reflected, and refracted mainly due to the impedance mismatch
between layers and signal scattering [136]. As a consequence signal dampening will occur and fetal
heart sounds will have a very narrow band of frequencies [127,128].
The next stage of research activity within the framework of this paper is to carry out animal
studies (preferably using a pig model as sheep and calf models are not generally suitable [137] for this
purpose). Clinical trials will be planned by leveraging our collaborative arrangements made with the
Department of Obstetrics and Gyneacology, at the Masaryk University and University Hospital in
Brno in the Czech Republic.
We express our readiness to carry out a detailed analysis of the applicability of patch monitors to
fHR monitoring. We are aware that wearable ’electronic patch monitors’ [138,139] are great candidates
for wireless continuous monitoring of biopotentials representing vital signs. In our most recent
research (submitted for publication) we specifically focused on signal processing techniques applicable
to the fetal electrocardiograms (fECGs) filtered from the abdominal (aECG) signals. Suppressing
the unwanted components (especially the maternal ECG) from the aECG signal proved to be a very
challenging task. In comparison to fECGs, fetal Phonocardiography, which is based on sensing the fetal
heart sounds on the maternal abdomen, produces a fetal PCG (fPCG) component, which is significantly
larger in amplitude than the fECG component in the abdominal ECG (aECG). Therefore, it is easier to
extract. For this purpose, we decided to utilize optical fibers, which are frequently used in many other
applications. The many other advantages of our proposed approach are described in our paper.
5. Conclusions
This paper deals with the design and implementation of a noninvasive fiber-optic sensor and
its associated adaptive signal processing system for fetal heart rate (fHR) monitoring. The probe
utilizes sensing elements operating on the basis of the Mach-Zehnder Interferometer, which offers
great potential for applications in modern noninvasive medicine. The performance of our system
was evaluated by using generated (synthetic) data comparable to real data with the added advantage
of providing the reference signal necessary for the performance evaluation of the adaptive filtering
system as well as the capability to model hypoxic states without causing any risk or danger to the fetus
and the mother. The system’s performance was evaluated by using both qualitative (gynecological
expert knowledge and experience) and quantitative measures such as SNR, RMSE, S+, and PPV.
Our experimental results demonstrated that the NLMS Algorithm produced better outcomes
in the determination of fHR information based on S+, PPV measures, whereas the LMS Algorithm
performed better when SNR and RMSE parameters where used to evaluate the system’s performance.
Our findings further confirmed that signal filtering efficiency was not influenced by the form of fPCG
signals (physiological or pathological) when evaluated based on SNR, RMSE, S+, and PPV parameters.
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In summary, our paper presents the first attempt of its kind towards developing the techniques
and methods for noninvasive continuous fHR monitoring by using interferometric fiber-optic sensors.
The area of research dealing with fetal PCGs measured by these sensors is an uncharted territory that
warrants further extensive clinical investigations to be carried out in the future.
Our realized noninvasive adaptive system using fiber-optic interferometric sensors can
significantly contribute to the future research in fHR monitoring and can even be considered for
application in the Magnetic Resonance Imaging (MRI) and wet environments. We are very excited
that the clinicians at the University Hospital, Brno, in the Czech Republic, intend to use the system
reported here for their short term clinical studies in the near future.
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